Phase 2 trial of intensity-modulated radiation therapy +/- concurrent doxorubicin for patients with locally advanced or recurrent non-anaplastic thyroid cancer Meeting Abstract


Authors: Romesser, P. B.; Sherman, E.; Shaha, A.; Sabra, M.; Sabol, C.; Brinkman, T.; Spielsinger, D.; Tuttle, R. M.; Fagin, J.; Wong, R. J.; Lee, N.
Abstract Title: Phase 2 trial of intensity-modulated radiation therapy +/- concurrent doxorubicin for patients with locally advanced or recurrent non-anaplastic thyroid cancer
Meeting Title: 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO)
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 99
Issue: 2 Suppl.
Meeting Dates: 2017 Sep 24-27
Meeting Location: San Diego, CA
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2017-10-01
Start Page: E368
Language: English
ACCESSION: WOS:000411559103044
PROVIDER: wos
DOI: 10.1016/j.ijrobp.2017.06.1481
Notes: Meeting Abstract: 2873 -- Source: Wos
Altmetric Score
MSK Authors
  1. James A Fagin
    116 Fagin
  2. Ashok R Shaha
    557 Shaha
  3. Robert M Tuttle
    374 Tuttle
  4. Eric J Sherman
    182 Sherman
  5. Nancy Y. Lee
    599 Lee
  6. Richard J Wong
    239 Wong
  7. Mona M Sabra
    34 Sabra
  8. Christopher Sabol
    9 Sabol